Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Prostate Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 20 articles: HTML format Text format

Single Articles

January 2019
1. LORENZO G, Hughes TJR, Dominguez-Frojan P, Reali A, et al
   Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.
   Proc Natl Acad Sci U S A. 2019 Jan 7. pii: 1815735116.
   PubMed     Text format     Abstract available
   
   
   December 2018
2. ZADRA G, Ribeiro CF, Chetta P, Ho Y, et al
   Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
   Proc Natl Acad Sci U S A. 2018 Dec 21. pii: 1808834116.
   PubMed     Text format     Abstract available
   
   
   November 2018
3. FONG LY, Jing R, Smalley KJ, Wang ZX, et al
   Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.
   Proc Natl Acad Sci U S A. 2018;115:E11091-E11100.
   PubMed     Text format     Abstract available
   
   
   October 2018
4. ARORA H, Panara K, Kuchakulla M, Kulandavelu S, et al
   Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth.
   Proc Natl Acad Sci U S A. 2018 Oct 15. pii: 1812704115.
   PubMed     Text format     Abstract available
   
   
   
5. FENG S, Cheng X, Zhang L, Lu X, et al
   Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers.
   Proc Natl Acad Sci U S A. 2018;115:10094-10099.
   PubMed     Text format     Abstract available
   
   
   September 2018
6. 
   Correction for Chen et al., Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
   Proc Natl Acad Sci U S A. 2018;115:E9025.
   PubMed     Text format    
   
   
   August 2018
7. DUDANI JS, Ibrahim M, Kirkpatrick J, Warren AD, et al
   Classification of prostate cancer using a protease activity nanosensor library.
   Proc Natl Acad Sci U S A. 2018 Aug 20. pii: 1805337115.
   PubMed     Text format     Abstract available
   
   
   June 2018
8. NAVARRO HI, Goldstein AS
   HoxB13 mediates AR-V7 activity in prostate cancer.
   Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1808196115.
   PubMed     Text format    
   
   
   May 2018
9. CHEN Z, Wu D, Thomas-Ahner JM, Lu C, et al
   Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
   Proc Natl Acad Sci U S A. 2018 May 29. pii: 1718811115.
   PubMed     Text format     Abstract available
   
   
   April 2018
10. FAN L, Zhang F, Xu S, Cui X, et al
    Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802415115.
    PubMed     Text format     Abstract available
    
    
    
11. TAKAYAMA KI, Suzuki T, Fujimura T, Takahashi S, et al
    COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1721957115.
    PubMed     Text format     Abstract available
    
    
    
12. LEE JK, Bangayan NJ, Chai T, Smith BA, et al
    Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1802354115.
    PubMed     Text format     Abstract available
    
    
    
13. ELLIS L, Loda M
    LSD1: A single target to combat lineage plasticity in lethal prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 16. pii: 1804205115.
    PubMed     Text format    
    
    
    
14. POWELL GRAY B, Kelly L, Ahrens DP, Barry AP, et al
    Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 16. pii: 1717705115.
    PubMed     Text format     Abstract available
    
    
    March 2018
15. SEHRAWAT A, Gao L, Wang Y, Bankhead A 3rd, et al
    LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
    Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 1719168115.
    PubMed     Text format     Abstract available
    
    
    February 2018
16. HASHIMOTO K, Ochi H, Sunamura S, Kosaka N, et al
    Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Proc Natl Acad Sci U S A. 2018;115:2204-2209.
    PubMed     Text format     Abstract available
    
    
    October 2017
17. KUNDU M, Roy A, Pahan K
    Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-gamma.
    Proc Natl Acad Sci U S A. 2017;114:11482-11487.
    PubMed     Text format     Abstract available
    
    
    September 2017
18. TAKAYAMA KI, Suzuki T, Fujimura T, Yamada Y, et al
    Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.
    Proc Natl Acad Sci U S A. 2017 Sep 11. pii: 201706076.
    PubMed     Text format     Abstract available
    
    
    June 2017
19. FEI T, Chen Y, Xiao T, Li W, et al
    Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.
    Proc Natl Acad Sci U S A. 2017 Jun 13. pii: 201617467.
    PubMed     Text format     Abstract available
    
    
    May 2017
20. 
    Correction for Dash et al., Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
    Proc Natl Acad Sci U S A. 2017 May 22. pii: 201706353.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: